Flux Power Holdings, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, | June 30, | |
|---|---|---|
| 2026 | 2025 | |
| ASSETS | ||
| Current assets: | ||
| Cash | $372,000 | $1,334,000 |
| Accounts receivable, net of allowance for credit losses of $86,000 and $68,000 at March 31, 2026 and June 30, 2025, respectively | 3,864,000 | 11,374,000 |
| Inventories, net | 16,656,000 | 17,231,000 |
| Other current assets | 2,539,000 | 1,865,000 |
| Total current assets | 23,431,000 | 31,804,000 |
| Right of use assets, net | 748,000 | 1,275,000 |
| Property, plant and equipment, net | 1,331,000 | 1,554,000 |
| Other assets | 92,000 | 119,000 |
| Total assets | $25,602,000 | $34,752,000 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities: | ||
| Accounts payable | $8,268,000 | $16,295,000 |
| Accrued expenses | 5,637,000 | 7,058,000 |
| Line of credit | 5,722,000 | 13,627,000 |
| Subordinated debt | - | 1,000,000 |
| Deferred revenue | 142,000 | 459,000 |
| Customer deposits | 62,000 | 38,000 |
| Finance leases payable, current portion | 87,000 | 80,000 |
| Office leases payable, current portion | 621,000 | 815,000 |
| Accrued interest | 53,000 | 246,000 |
| Total current liabilities | 20,592,000 | 39,618,000 |
| Long term liabilities: | ||
| Finance leases payable, less current portion | 22,000 | 32,000 |
| Office leases payable, less current portion | 83,000 | 506,000 |
| Deferred revenue, less current portion | 292,000 | - |
| Total liabilities | 20,989,000 | 40,156,000 |
| Commitments and contingencies (Note 11) | - | |
| Stockholders’ equity (deficit): | ||
| Preferred stock, $.001 par value; 3,000,000 and 500,000 shares authorized at March 31, 2026 and June 30, 2025, respectively; none issued and outstanding | - | - |
| Common stock, $0.001 par value; 75,000,000 shares authorized; 21,361,383 and 16,835,698 issued and outstanding at March 31, 2026 and June 30, 2025, respectively | 21,000 | 17,000 |
| Additional paid-in capital | 116,114,000 | 100,965,000 |
| Accumulated deficit | (111,522,000) | (106,386,000) |
| Total stockholders’ equity (deficit) | 4,613,000 | (5,404,000) |
| Total liabilities and stockholders’ equity (deficit) | $25,602,000 | $34,752,000 |
Page 5
CONDENSED CONSOLIDATED STATEMENTS OF OPERAITONS
| Three months ended March 31, | Nine months ended March 31, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenues | $6,588,000 | $16,742,000 | $33,884,000 | $49,697,000 |
| Cost of sales | 4,788,000 | 11,455,000 | 23,424,000 | 33,729,000 |
| Gross profit | 1,800,000 | 5,287,000 | 10,460,000 | 15,968,000 |
| Operating expenses: | ||||
| Selling and administrative | 4,168,000 | 5,717,000 | 12,638,000 | 16,817,000 |
| Research and development | 623,000 | 1,147,000 | 2,196,000 | 3,419,000 |
| Total operating expenses | 4,791,000 | 6,864,000 | 14,834,000 | 20,236,000 |
| Operating loss | (2,991,000) | (1,577,000) | (4,374,000) | (4,268,000) |
| Interest expense, net | (184,000) | (362,000) | (762,000) | (1,227,000) |
| Net loss | $(3,175,000) | $(1,939,000) | $(5,136,000) | $(5,495,000) |
| Net loss per share - basic and diluted | $(0.15) | $(0.12) | $(0.27) | $(0.33) |
| Weighted average number of common shares outstanding - basic and diluted | 21,340,371 | 16,684,320 | 19,289,746 | 16,683,074 |
Page 6
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
| Common Stock · Additional Paid-in · Accumulated | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Total | |
| Balance at June 30, 2025 | 16,835,698 | $17,000 | $100,965,000 | $(106,386,000) | $(5,404,000) |
| Issuance of preferred stock warrants and common stock warrants under Private Placement, net of offering costs of $400,000 | - | - | 4,400,000 | - | 4,400,000 |
| Issuance of common stock – ESPP | 26,312 | - | 37,000 | - | 37,000 |
| Stock-based compensation | - | - | 209,000 | - | 209,000 |
| Net loss | - | - | - | (2,562,000) | (2,562,000) |
| Balance at September 30, 2025 | 16,862,010 | 17,000 | 105,611,000 | (108,948,000) | (3,320,000) |
| Issuance of common stock under Public Offering, net of offering costs of $1,280,000 | 4,416,000 | 4,000 | 9,756,000 | - | 9,760,000 |
| Issuance of preferred stock warrants and common stock warrants under Private Placement, net of offering costs of $245,000 | - | - | (45,000) | - | (45,000) |
| Issuance of common stock – exercised options | 62,125 | - | 255,000 | - | 255,000 |
| Stock-based compensation | - | - | 285,000 | - | 285,000 |
| Net income | - | - | - | 601,000 | 601,000 |
| Balance at December 31, 2025 | 21,340,135 | 21,000 | 115,862,000 | (108,347,000) | 7,536,000 |
| Offering costs in connection with the issuance of preferred stock warrants and common stock warrants under Private Placement | - | - | (7,000) | - | (7,000) |
| Issuance of common stock - ESPP | 21,248 | - | 19,000 | - | 19,000 |
| Stock-based compensation | - | - | 240,000 | - | 240,000 |
| Net income | - | - | - | (3,175,000) | (3,175,000) |
| Balance at March 31, 2026 | 21,361,383 | $21,000 | $116,114,000 | $(111,522,000) | $4,613,000 |
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | Capital Stock Amount | Additional Paid-in Capital | Accumulated Deficit | Total | |
| Balance at June 30, 2024 | 16,682,465 | $17,000 | $99,889,000 | $(99,712,000) | $194,000 |
| Stock-based compensation | - | - | 347,000 | - | 347,000 |
| Net loss | - | - | - | (1,669,000) | (1,669,000) |
| Balance at September 30, 2024 | 16,682,465 | 17,000 | 100,236,000 | (101,381,000) | (1,128,000) |
| Stock-based compensation | - | - | 278,000 | - | 278,000 |
| Net loss | - | - | - | (1,887,000) | (1,887,000) |
| Balance at December 31, 2024 | 16,682,465 | 17,000 | 100,514,000 | (103,268,000) | (2,737,000) |
| Issuance of common stock – exercised options | 34,668 | - | - | - | - |
| Issuance of common stock – ESPP | 50,337 | - | 98,000 | - | 98,000 |
| Stock-based compensation | - | - | 206,000 | - | 206,000 |
| Net loss | - | - | - | (1,939,000) | (1,939,000) |
| Balance at March 31, 2025 | 16,767,470 | $17,000 | $100,818,000 | $(105,207,000) | $(4,372,000) |
Page 7
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine months ended March 31, | ||||
|---|---|---|---|---|
| 2026 · 2025 | ||||
| Cash flows from operating activities: | ||||
| Net loss | $(5,136,000) | $(5,495,000) | ||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||
| Depreciation and amortization | 747,000 | 750,000 | ||
| Stock-based compensation | 734,000 | 831,000 | ||
| Amortization of debt issuance costs | 57,000 | 123,000 | ||
| Allowance for credit losses | 12,000 | 1,000 | ||
| Non-cash lease expense | 547,000 | 493,000 | ||
| Inventory write downs | 86,000 | 592,000 | ||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | 7,498,000 | (197,000) | ||
| Inventories | 489,000 | (48,000) | ||
| Other assets | (613,000) | 259,000 | ||
| Accounts payable | (8,027,000) | 3,471,000 | ||
| Accrued expenses | (1,421,000) | 1,759,000 | ||
| Accrued interest | (20,000) | 68,000 | ||
| Office leases payable | (617,000) | (543,000) | ||
| Deferred revenue | (25,000) | 124,000 | ||
| Customer deposits | 24,000 | 20,000 | ||
| Net cash (used in) provided by operating activities | (5,665,000) | 2,208,000 | ||
| Cash flows from investing activities: | ||||
| Purchases of equipment | (405,000) | (498,000) | ||
| Net cash used in investing activities | (405,000) | (498,000) | ||
| Cash flows from financing activities: | ||||
| Proceeds from issuance of preferred and common stock warrants under Private Placement | 3,827,000 | - | ||
| Offering costs for issuance of preferred and common stock warrants | (652,000) | - | ||
| Proceeds from issuance of common stock under Public Offering | 11,040,000 | - | ||
| Offering costs for issuance of common stock | (1,280,000) | - | ||
| Proceeds from subordinated debt borrowing | - | 1,000,000 | ||
| Proceeds from stock option exercises and employee stock purchase plan purchases | 311,000 | 98,000 | ||
| Proceeds from revolving line of credit | 46,831,000 | 46,914,000 | ||
| Payment of revolving line of credit | (54,736,000) | (49,744,000) | ||
| Cost to amend line of credit agreement | (113,000) | - | ||
| Payment of finance leases | (120,000) | (116,000) | ||
| Net cash provided by (used in) financing activities | 5,108,000 | (1,848,000) | ||
| Net change in cash | (962,000) | (138,000) | ||
| Cash, beginning of period | 1,334,000 | 643,000 | ||
| Cash, end of period | $372,000 | $505,000 | ||
| Supplemental Disclosures of Non-Cash Investing and Financing Activities: | ||||
| Right-of-use asset recognition | $139,000 | $ | - | |
| Preferred and common stock warrants issued under Private Placement in exchange for settlement of subordinated debt, including interest accrued | $1,173,000 | $ | - | |
| Common stock issued for vested RSUs | $ | - | $65,000 | |
| Supplemental Cash Flow Information: | ||||
| Interest paid | $766,000 | $947,000 | ||
Page 8
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2026
NOTE 1 -NATURE OF BUSINESS
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a smaller reporting company, which require the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited financial statements and revenues and expenses during the periods reported. Management has considered the implications of ongoing global events and related economic impacts to the estimates and assumptions used in the preparation of the condensed consolidated financial statements. There is heightened volatility and uncertainty around tariff actions, supply chain performance and customer demand. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of March 31, 2026 through the filing date of this quarterly report on Form 10-Q.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025, filed with the SEC on September 17, 2025. In the opinion of management, the accompanying unaudited condensed consolidated interim financial statements include all adjustments necessary in order to make the financial statements not misleading. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period. Certain notes to the financial statements that would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal year as reported in the Company’s Annual Report on Form 10-K have been omitted. The accompanying unaudited condensed consolidated balance sheet at June 30, 2025 has been derived from the audited balance sheet at June 30, 2025 contained in such Form 10-K.
Nature of Business
Flux Power Holdings, Inc. (“Flux”) was incorporated in 2009 in the State of Nevada, and Flux’s operations are conducted through its wholly owned subsidiary, Flux Power, Inc. (“Flux Power”), a California corporation (collectively, the “Company”).
We design, develop, manufacture and sell a portfolio of advanced lithium-ion energy storage solutions for electrification of a range of industrial and commercial sectors which include material handling and airport ground support equipment (“GSE”). We believe our mobile and stationary energy storage solutions provide our customers a reliable, high performing, cost effective, and more environmentally friendly alternative as compared to traditional lead acid and propane-based solutions. Our modular and scalable design allows different configurations of lithium-ion energy storage solutions to be paired with our proprietary wireless battery management system to provide the level of energy storage required and “state of the art” real time monitoring of pack performance. We believe that the increasing demand for lithium-ion energy storage solutions and more environmentally friendly energy storage solutions in the material handling sector should continue to drive our revenue growth.
Page 9
Business Trends and Uncertainties
Since January 2025, the U.S. government has increased certain existing import tariffs and implemented new import tariffs across a wide range of countries at various rates, including on product imports from almost all countries, and individualized higher tariffs on certain countries, notably China. Some of these tariff announcements have since been followed by announcements of limited exemptions and temporary pauses and all have been affected by various circuit court decisions and a key decision by the U.S. Supreme Court, which invalidated certain tariffs. In response to the U.S. Supreme Court ruling, the Trump administration debuted a system for repaying importers for tariffs struck down by the U.S. Supreme Court while also announcing the implementation of new tariffs under an alternative statutory authority and indicating a desire to further increase such tariffs and to seek to extend such tariffs under other statutes. The full impact of the U.S. Supreme Court’s ruling and the administration’s response, including the timing and extent of any refunds and the impact of the new tariffs, remains uncertain.
The Company imports a portion of its raw materials and components from countries that are subject to import tariffs imposed by the U.S. government, in particular materials and components that are from China. While the Company has been able to offset some of the impact of enacted tariffs with supply chain adjustments, alternative manufacturing locations, cost reduction actions and by increasing selling prices of its products, the Company believes that tariffs have negatively impacted its revenues, profitability and cash flows. Management continues to actively evaluate ways to mitigate the impacts of tariffs on business and financial results, however, due to the uncertainties pertaining to tariffs and tariff levels, it is difficult for the Company to reliably forecast the extent of the ongoing impact to its business or to its customers.
Trade-related disruptions can create further uncertainty and supply chain interruptions, which may result in last-minute procurement efforts at elevated cost. The Company is closely monitoring the fluid nature of proposed tariffs and any impact they may have on its operations, and will continue to monitor macroeconomic conditions and evaluate the financial and operational impact of ongoing trade policy shifts. These risks could intensify depending on future developments, and the Company is actively incorporating these considerations into its future operation planning, including assessing pricing actions, cost-control measures, and long-term sourcing strategies.
If tariffs escalate or global inflationary trends persist, the Company’s customers may face greater economic strain, which could in turn affect demand for its products. The Company remains focused on maintaining operational flexibility and adapting its supply chain to navigate these uncertainties and support long-term business performance. See “Risk Factors” under Part I, Item 1A of this Quarterly Report for additional information.
Liquidity and Financial Condition
The accompanying unaudited condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
Historically, the Company’s revenues and operating cash flows have not been sufficient to sustain its operations and the Company has relied on debt and equity financing, including the Public Offering (as described below), for additional funds. The Company has incurred an accumulated deficit of $111.5 million through March 31, 2026, and for the nine months ended March 31, 2026 incurred a net loss of $5.1 million and utilized $5.7 million in support of operating activities. As of March 31, 2026, the Company had a cash balance of $0.4 million and $10.3 million of available funding under the Gibraltar Business Capital (“GBC”) Credit Facility, subject to borrowing base limitations (See Note 6 – Line of Credit). The Company’s borrowing base changes as qualified collateral fluctuates and, therefore, available funding under the GBC Credit Facility (as defined below) could be substantially lower.
In addition, the Company’s ability to meet projected revenue targets and generate cash from operations has been impacted by delays in new orders for our energy storage solutions, reflecting corresponding deferrals of new forklift purchases by selected large customer fleets due to lower capital spending and interest rate variability, and more recently, global tariff uncertainties.
The Company imports a portion of its raw materials and components parts from other countries, including China. Recently, many of the countries where the Company sources raw materials and component parts have become subject to import tariffs upon entry into the United States. The selling prices of the Company’s finished products have been increased due to increased tariff levels in effect, which may have a negative impact on the Company’s revenues and cash flows.
Page 10
The Company has implemented reductions in labor and overhead costs and has increased selling prices of energy storage solutions, however, management is evaluating strategies to further improve profitability of operations. Gross margin improvement tasks include but are not limited to a plan to drive bill of material costs down. The Company continues to execute cost reduction, sourcing and pricing recovery initiatives in efforts to increase gross margins and improve cash flow from operations.
During the nine months ended March 31, 2026, the Company completed a Private Placement of Preferred Stock Warrants and Common Stock Warrants, and raised $3.2 million in cash proceeds, net of offering costs of $0.7 million and the cancellation of $1.2 million of outstanding debt. The Company also completed the Public Offering of its common stock and raised $9.8 million in cash proceeds, net of offering costs of $1.3 million. See Note 8 – Stockholders’ Equity (Deficit) for additional information.
Management has evaluated the Company’s expected cash and working capital requirements, which include, but are not limited to, investments in additional sales and marketing, research and development and capital equipment, as well as the Company’s expected funding sources, which include, but are not limited to, the Company’s existing cash, forecasted gross margin and funding available under the GBC Credit Facility, subject to certain restrictions, covenants and borrowing base limitations. The Company’s borrowing base changes as qualified collateral fluctuates and, therefore, available funding under the GBC Credit Facility could be substantially lower.
As of March 31, 2026, the Company determined that the Company failed to comply with the minimum EBITDA financial covenant for the trailing three-month period ended March 31, 2026 under the GBC Credit Facility, which resulted in an “event of default” under the GBC Credit Facility. The Company is working with GBC to negotiate an amendment to the GBC Credit Facility or otherwise obtain a waiver from GBC. GBC has allowed the Company to continue to have access to its line of credit under the GBC Credit Facility while negotiations continue, however, GBC can choose to limit this access at any time until the Company can successfully negotiate an amendment to the GBC Credit Facility or obtain a waiver from GBC. While the Company has in the past successfully renegotiated the terms of the GBC Credit Facility, and is optimistic about its ability to do so again, there can be no assurances that the Company will be able to negotiate an amendment to the GBC Credit Facility or obtain a waiver from GBC on terms favorable to the Company or at all. In addition, upon the occurrence of an event of default under the GBC Credit Facility, GBC may, at its option, declare its commitments to the Company terminated and all of the Company’s obligations under the GBC Credit Facility immediately due and payable, all without demand, notice or further action of any kind required on the part of GBC, and/or exercise other remedies available to it, which include, among other things, its rights as a secured party under the GBC Credit Facility. Since GBC can choose to limit the Company’s access to its line of credit under the GBC Credit Facility at any time and successful negotiation of an amendment to the GBC Credit Facility or a waiver from GBC cannot be guaranteed, substantial doubt exists about the Company’s ability to continue as a going concern over the 12 months following the filing date of this report on Form 10-Q.
Page 11
Nasdaq Stock Market Notices
As previously disclosed, on January 31, 2025 the Staff of Nasdaq notified the Company that it did not comply with the Stockholders’ Equity Requirement. On March 17, 2025, the Company filed its plan with Nasdaq to regain compliance with the Stockholders’ Equity Requirement, which included requesting an extension through July 30, 2025. On July 31, 2025, due to non-compliance with the Stockholders’ Equity Requirement, the Staff informed the Company that trading of the Company’s common stock would be suspended at the opening of business on August 11, 2025 unless the Company requested an appeal of the Staff’s determination to a Nasdaq Hearings Panel (the “Panel”). The Company requested an appeal hearing with the Panel and the Panel determined to grant the Company an exception to demonstrate compliance with the Stockholders’ Equity Requirement and furthermore granted the Company its request for continued listing, which extension was subject to, among other requirements, the Company demonstrating compliance with the Stockholder’s Equity Requirement on or before October 31, 2025.
On October 14, 2025, the Company received a notification (the “Notification”) from the Listing Qualifications Department (the “Staff”) of Nasdaq that the Company had regained compliance with Nasdaq’s continued listing rules because the Company met the requirement to have a market value of listed securities of at least $35 million (the “Market Equity Requirement”). Nasdaq requires that for continued listing on the Nasdaq Capital Market, the Company must continue to meet all the requirements set forth in Rule 5550(a) and at least one of the standards set forth in Rule 5550(b). The standards set forth in 5550(b) include (i) having a minimum of $2,500,000 in stockholders’ equity (the “Stockholders’ Equity Requirement”), (ii) the Market Equity Requirement, or (iii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years (the “Net Income Requirement”). The Notification also provided that, for a period of one year, the Staff of Nasdaq will monitor the Company’s compliance with the continued listing requirements. If, during such one-year period, the Company fails to comply with Rule 5550(b), the Staff of Nasdaq will issue a delist determination letter and the Company will have an opportunity to request a new hearing.
As of March 31, 2026, the Company also satisfies the Stockholder’s Equity Requirement, however, the Company can provide no assurances that it will be able to continue to comply with either the Market Equity Requirement or the Stockholder’s Equity Requirement. If the Company fails to comply with the Nasdaq continued listing requirements, the Company’s common stock will be subject to delisting by Nasdaq. In the event our common stock is delisted, our stock price and market liquidity of our stock will be adversely affected which will impact the ability of the Company’s stockholders to sell securities in the market. Further, delisting from Nasdaq could also have other negative effects, including potential loss of confidence by partners, lenders, suppliers and employees.
NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Company’s significant accounting policies are described in Note 2 – Summary of Significant Accounting Policies to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. There have been no material changes in these policies or their application.
Recently Issued Accounting Pronouncements
In December 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2025-12,Codification Improvements, which clarifies, corrects errors and makes minor improvements to Generally Accepted Accounting Principles. The amendments in the Update will not result in significant changes to the Company’s presentation of its financial statements.
In December 2025, the FASB issued ASU 2025-11,Interim Reporting (Topic 270): Narrow-Scope Improvements, which improves the guidance in Topic 270 by improving the navigability of the required interim disclosures, clarifying when that guidance is applicable and providing additional guidance on what disclosures should be provided in interim reporting periods. The ASU adds to Topic 270 a principle that requires entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. The ASU is effective for the Company’s fiscal year ending June 30, 2030 and interim periods within. Early adoption is permitted. The Company is evaluating the impact of the new standard.
In July 2025, the FASB issued ASU 2025-05,*Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,*which allows companies to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. The ASU is effective on a prospective basis for the Company’s fiscal year ending June 30, 2027 and interim periods within. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued. The Company is evaluating the impact of the new standard.
In November 2024, the FASB issued ASU 2024-03,Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses, which requires additional disclosure of certain amounts included in the expense captions presented on the statement of operations, as well as disclosures about selling expenses. The ASU is effective on a prospective basis, with the option for retrospective application, for the company’s fiscal year ending June 30, 2028 and interim periods thereafter. Early adoption is permitted for annual financial statements that have not yet been issued. The Company is evaluating the disclosure requirements related to the new standard.
In December 2023, the FASB issued ASU 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires more detailed income tax disclosures on an annual basis. The guidance requires entities to disclose disaggregated information about their effective tax rate reconciliation as well as expanded information on income taxes paid by jurisdiction. The disclosure requirements will be applied on a prospective basis, with the option to apply them retrospectively. The standard is effective for the Company’s Annual Report on Form 10-K for the fiscal year ending June 30, 2026. The Company is evaluating the disclosure requirements related to the new standard.
Recently Adopted Accounting Pronouncements
The Company did not adopt any new accounting pronouncements during the nine months ended March 31, 2026.
Page 12
NOTE 3 – INVENTORIES
Inventories consist of the following:
| March 31, 2026 | June 30, 2025 | |
|---|---|---|
| Raw materials | $12,535,000 | $13,471,000 |
| Work in process | 591,000 | 513,000 |
| Finished goods | 3,530,000 | 3,247,000 |
| Total inventory | $16,656,000 | $17,231,000 |
NOTE 4 –OTHER CURRENT ASSETS
Other current assets consist of the following:
| March 31, 2026 | June 30, 2025 | |
|---|---|---|
| Lawsuit insurance receivable | $1,923,000 | $1,486,000 |
| Prepaid computer support service | 151,000 | 111,000 |
| Prepaid insurance | 137,000 | 104,000 |
| Prepaid advertising, promotion and trade show | 79,000 | 5,000 |
| Prepaid expenses | 75,000 | 17,000 |
| Prepaid professional and consulting | 54,000 | 15,000 |
| Other | 120,000 | 127,000 |
| Total other current assets | $2,539,000 | $1,865,000 |
NOTE 5 – ACCRUED EXPENSES
Accrued expenses consist of the following:
| March 31, 2026 | June 30, 2025 | |
|---|---|---|
| Warranty liability | $2,833,000 | $3,377,000 |
| Lawsuit settlements liability | 1,937,000 | 2,175,000 |
| Payroll and bonus accrual | 408,000 | 1,024,000 |
| PTO accrual | 459,000 | 482,000 |
| Total accrued expenses | $5,637,000 | $7,058,000 |
Page 13
NOTE 6 –LINE OF CREDIT
Revolving Line of Credit - Gibraltar Business Capital Credit Facility
On July 28, 2023, the Company entered into a Loan and Security Agreement (the “Loan and Security Agreement”) with Gibraltar Business Capital (“GBC”) (the “GBC Credit Facility”). The Loan and Security Agreement provides the Company with a senior secured revolving loan facility for up to $15.0 million, which was increased by amendment, see below (the “Revolving Loan Commitment”). The revolving amount available under the GBC Credit Facility is equal to the lesser of the Revolving Loan Commitment and the borrowing base amount (as defined in the Loan and Security Agreement). The GBC Credit Facility is evidenced by a revolving note, which was to mature on July 28, 2025 (the “Maturity Date”), and was extended prior to maturity by amendment, see below (the “Revolving Note”). Concurrently, the Company entered into an Intellectual Property Security Agreement.
In addition, subject to conditions and terms set forth in the Loan and Security Agreement, the Company may request an increase in the Revolving Loan Commitment from time to time upon not less than 30 days’ notice to GBC which increase may be made at the sole discretion of GBC, as long as: (a) the requested increase is in a minimum amount of $1,000,000, and (b) the total increases do not exceed $5,000,000 and no more than five (5) increases are made. On January 30, 2024, the Company entered into Amendment No. 2 to the Loan and Security Agreement with GBC, pursuant to which, among other things, the Revolving Loan Commitment was increased to $16.0 million. Outstanding principal under the GBC Credit Facility accrues interest at Secured Overnight Financing Rate (“SOFR”, as defined in the Loan and Security Agreement) plus five and one half of one percent (5.50%) per annum with such interest payment due monthly on the last day of the month. In the event of default, the amounts due under the Loan and Security Agreement bear interest at a rate per annum equal to three percent (3.0%) above the rate that is otherwise applicable to such amounts. The Company paid GBC a non-refundable closing fee for the GBC Credit Facility of $112,500 upon the execution of the Loan and Security Agreement. In addition, the Company is required to pay a monthly unused line fee equal to one-half of one percent (0.50%) per annum on the difference between the Revolving Loan Commitment and the average outstanding principal balance of the revolving loan(s) for such month. The obligations under the GBC Credit Facility may be prepaid in whole or in part at any time upon an exit fee of (a) two percent (2.00%) of the Revolving Loan Commitment if the obligations are paid in full during the first year after the closing date, or (b) one percent (1.00%) of the Revolving Loan Commitment if the obligations are paid in full one year after the closing date, provided, that, the exit fee will be waived if such prepayment occurs in connection with the refinancing of the obligations with Bank of America, N.A., as lender.
On January 22, 2025, the Company entered into Amendment No. 4 to the Loan and Security Agreement (the “Fourth Amendment”) with GBC which amended certain terms of the Loan and Security Agreement, as amended, relating to the EBITDA Minimum financial covenant of the Company. In consideration for the Fourth Amendment, the Company agreed to pay GBC a non-refundable amendment fee of $50,000 in cash, as follows: (i) $25,000 paid on March 1, 2025, and (ii) $25,000 paid on April 1, 2025.
On July 16, 2025, the Company entered into Amendment No. 5 to the Loan and Security Agreement (the “Fifth Amendment”) with GBC which amended certain terms relating to the maturity date set forth under the Loan and Security Agreement, as amended. Pursuant to the Fifth Amendment, GBC and the Company agreed to amend the of the maturity date to August 31, 2025, unless otherwise extended pursuant to the terms of the Loan and Security Agreement, provided however, upon the occurrence of either (i) an extension of the due date of the Cleveland Note to a date no earlier than September 29, 2027, or (ii) the conversion of all of the outstanding obligations under the Cleveland Note into equity of the Company, the maturity date will automatically extend to July 31, 2027. In consideration for the Fifth Amendment, the Company agreed to pay GBC a non-refundable amendment fee of $112,500.
On September 4, 2025, the Company entered into Amendment No. 6 to the Loan and Security Agreement (the “Sixth Amendment”), with the effective date of August 31, 2025, which amended certain terms of the Loan Agreement, including (i) modifications to the EBITDA minimum financial covenant of the Company, and (ii) an extension of the maturity date from August 31, 2025 to September 15, 2025, subject to acceleration or further extension pursuant to the terms of the Loan Agreement. Upon the closing of the Private Placement on September 15, 2025, all the outstanding obligations under the Cleveland Note were applied in full towards satisfaction of the subscription by Cleveland in the Private Placement. Upon the conversion of all the outstanding obligations under the Cleveland Note into equity of the Company, the Maturity Date of the Loan and Security Agreement was automatically extended to July 31, 2027 according to the Fifth Amendment.
The loans and other obligations of the Company under the GBC Credit Facility are secured by substantially all of the tangible and intangible assets of the Company (including, without limitation, intellectual property) pursuant to the terms of both the July 31, 2023 Loan and Security Agreement and the Intellectual Property Security Agreement. During the nine months ended March 31, 2026, the Company’s multiple drawdowns and repayments under the GBC Credit Facility resulted in a net $7.9 million repayment. As of March 31, 2026, the outstanding balance under the GBC Credit Facility was approximately $5.7 million, with up to $10.3 million available for future borrowings, subject to borrowing base limitations. The Company’s borrowing base changes as qualified collateral fluctuates and, therefore, available funding under the GBC Credit Facility could be substantially lower. Additionally, as discussed in Note 1, on March 31, 2026, the Company determined that the Company failed to comply with the minimum EBITDA financial covenant for the trailing three-month period ended March 31, 2026 under the GBC Credit Facility, which resulted in an “event of default” under the GBC Credit Facility. The Company is working with GBC to negotiate an amendment to the GBC Credit Facility or otherwise obtain a waiver from GBC. GBC has allowed the Company to continue to have access to its line of credit under the GBC Credit Facility while negotiations continue, however, GBC can choose to limit this access at any time until the Company can successfully negotiate an amendment to the GBC Credit Facility or obtain a waiver from GBC.
NOTE 7 -SUBORDINATED DEBT
Related Party Credit Facility - Cleveland Capital, L.P.
On November 2, 2023, the Company entered into a Credit Facility Agreement (the “Cleveland Credit Facility”) with Cleveland Capital, L.P. (“Cleveland”). The Cleveland Credit Facility provides the Company with a line of credit of up to $2,000,000 for working capital purposes and the Company issued a Subordinated Unsecured Promissory Note for $2,000,000 (the “Commitment Amount”) in favor of Cleveland (the “Cleveland Note”).
Pursuant to the terms of the Cleveland Credit Facility, Cleveland agreed to make loans (each such loan, an “Advance”) up to such Lender’s Commitment Amount to the Company from time to time, until August 15, 2025 (the “Due Date”). The Cleveland Note accrues interest at Secured Overnight Financing Rate plus nine percent (9%) per annum on each Advance from and after the date of disbursement of such Advance. All indebtedness, obligations and liabilities of the Company to Cleveland are subject to the rights of GBC, pursuant to a Subordination Agreement dated on or about November 2, 2023, by and between Cleveland and GBC (the “Subordination Agreement”). Subject to the Subordination Agreement, the Company may, from time to time, prior to the Due Date, draw down, repay, and re-borrow on the Cleveland Note, by giving notice to Cleveland of the amount to be requested to be drawn down. Subject to the Subordinated Unsecured Promissory Note, the Cleveland Note is payable upon the earlier of (i) the Due Date or (ii) on occurrence of an event of Default (as defined in the Cleveland Note).
Page 14
As consideration of Cleveland’s commitment to provide the Advances to the Company, the Company issued 41,196 Common Stock Warrants to Cleveland (the “Cleveland Warrants”) which rights are represented by a warrant certificate (“Warrant Certificate”) entitling Cleveland to purchase 41,196 shares of common stock for an exercise price of $3.24 per share. Subject to certain ownership limitations, the Cleveland Warrants are exercisable immediately from the date of issuance, and expire on thefive-year anniversary of the date of issuance of November 2, 2023. The exercise price of the Cleveland Warrants is subject to certain adjustments, including stock dividends, stock splits, combinations and reclassifications of the common stock. In the event of a Triggering Event (as defined in the Warrant Certificate), the holder will be entitled to exercise and receive the same amount and kind of securities, cash or property as such holder would have been entitled to receive upon the occurrence of such Triggering Event if such holder had exercised the rights represented by the Warrant Certificate immediately prior to the Triggering Event. Additionally, upon the holder’s request, the continuing or surviving corporation as a result of such Triggering Event will issue to such holder a new warrant of like tenor evidencing the right to purchase the adjusted amount of securities, cash or property and the adjusted warrant price. (See Note 8 – Stockholders’ Equity (Deficit)).
On September 15, 2025, concurrent with the closing of the $5.0 million private placement described in Note 8 – Stockholders Equity (Deficit), Cleveland purchased 89,323 Preferred Stock Warrants and 420,335 Common Stock Warrants for approximately $1,730,000. This purchase was partially funded by the conversion of the carrying value of the outstanding principal and accrued interest of the Cleveland Credit Facility on September 14, 2025, of $1,173,000. Cleveland entered into a Debt Satisfaction Agreement with the Company pursuant to which Cleveland represented full payment and satisfaction of any and all obligations of the Company due to Cleveland under the Subordinated Unsecured Promissory Note dated November 2, 2023, as amended. Cleveland paid the remaining amount due under the placement of $557,000 in cash.
The outstanding balance of the Cleveland Credit Facility subordinated debt wasnone and $1,000,000 as of March 31, 2026 and June 30, 2025, respectively.
NOTE 8 – STOCKHOLDERS’ EQUITY (DEFICIT)
Under the Company’s Articles of Incorporation, amended on September 10, 2025, the Company is authorized to issue of up to 75,000,000 shares of common stock and 3,000,000 shares of preferred stock, of which 1,000,000 shares of preferred stock are designated for Series A Convertible Preferred Stock.
Private Placement
On July 18, 2025, the Company entered into a securities purchase agreement, which was amended and restated on September 15, 2025 (the “Amended and Restated Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) pursuant to which, among other things, the Purchasers agreed to subscribe for and purchase, and the Company agreed to issue and sell to the Purchasers, an aggregate of 258,144 Preferred Stock Warrants and 1,214,766 Common Stock Warrants at the aggregate purchase price of approximately $5.0 million (the “Private Placement”). The purchase price was paid in cash or, in the case of purchaser Cleveland, cash and the cancellation of certain existing debt of the Company held by Cleveland. See Note 7 – Subordinated Debt for additional information.
The Securities were offered to a small select group of accredited investors, as defined in Rule 501 of Regulation D, all of whom have a substantial pre-existing relationship with the Company, including certain executives and affiliates of the Company.
The closing of the Private Placement contemplated by the Amended and Restated Purchase Agreement occurred simultaneously on September 15, 2025 upon the satisfaction of certain customary conditions. Proceeds received, net of offering costs of approximately $652,000, were approximately $4,348,000 consisting of $3,175,000 cash and the aforementioned cancellation of $1,173,000 of outstanding debt. The Private Placement Common Stock Warrants and Preferred Stock Warrants are classified as equity. Accordingly, proceeds, net of offering costs, are included in additional paid-in capital on the Company’s unaudited condensed consolidated balance sheets.
Public Offering
On November 3, 2025, the Company completed an underwritten public offering (the “Public Offering”) of 3,840,000 shares of its common stock at a public offering price of $2.50 per share, and the Company granted the underwriter a 30-day option to purchase up to an additional 576,000 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, subsequently exercised in full. The Company received net proceeds of approximately $9,760,000, after offering costs of approximately $1,280,000.
Page 15
Common Stock Warrants
In connection with the Company’s registered direct offering (“RDO”) in September 2021, the Company issued five-year Common Stock Warrants to the RDO investors to purchase up to 1,071,430 shares of the Company’s common stock at an exercise price of $7.00 per share and were estimated to have a fair value of approximately $3,874,000.
In May 2022 and in conjunction with entry into a credit facility with Silicon Valley Bank (“SVB”), since terminated, the Company issued five-year Common Stock Warrants to purchase up to 128,000 shares of the Company’s common stock at an exercise price of $2.53 per share and had a fair value of approximately $173,000. These SVB Common Stock Warrants were subsequently transferred to Cleveland and others.
In June 2022 and in conjunction with the entry into an amendment of the credit facility with SVB, the Company issued twelve-year Common Stock Warrants to purchase up to 40,806 shares of the Company’s common stock at an exercise price of $2.23 per share and had a fair value of approximately $80,000.
In November 2023 and in conjunction with the entry into the 2023 Subordinated LOC with Cleveland, the Company issued Common Stock Warrants to purchase up to 41,196 shares of the Company’s common stock at an exercise price of $3.24 per share with a fair value of approximately $92,000.
In September 2025 and in conjunction with the Private Placement, the Company issued Common Stock Warrants to purchase up to 1,214,766 shares of the Company’s common stock at an exercise price of $1.715 per share and exercisable forfive years from date of issuance.
Activity in the Company’s Common Stock Warrants during the nine months ended March 31, 2026 is reflected below:
| Number of Common Stock Warrants | Weighted Average Exercise Price Per Warrant | Weighted Average Remaining Contract Term (years) | |
|---|---|---|---|
| Outstanding and exercisable at June 30, 2025 | 1,413,110 | $6.14 | 1.48 |
| Issued | 1,214,766 | $1.72 | 4.46 |
| Exercised | - | ||
| Expired and cancelled | (131,678) | $4.80 | |
| Outstanding and exercisable at March 31, 2026 | 2,496,198 | $4.06 | 2.62 |
Activity in the Company’s Common Stock Warrants during the nine months ended March 31, 2025 is reflected below:
| Number of Common Stock Warrants | Weighted Average Exercise Price Per Warrant | Weighted Average Remaining Contract Term (years) | |
|---|---|---|---|
| Outstanding and exercisable at June 30, 2024 | 1,413,110 | $6.14 | 2.48 |
| Issued | - | ||
| Exercised | - | ||
| Expired and cancelled | - | ||
| Outstanding and exercisable at March 31, 2025 | 1,413,110 | $6.14 | 1.73 |
Page 16
Preferred Stock Warrants
In September 2025 and in conjunction with the Private Placement, the Company issued Preferred Stock Warrants to purchase up to 258,144 shares of the Company’s Series A Preferred Stock at an exercise price of $0.001 per share which are then convertible to 2,429,523 shares of common stock, subject to certain adjustments. The Preferred Stock Warrants do not expire. Activity during the nine months ended March 31, 2026 is reflected below:
| Number of Preferred Warrants | Weighted Average Exercise Price per Warrant | Convertible to Common Shares | Weighted Average Remaining Contract Term (years) | |
|---|---|---|---|---|
| Outstanding and exercisable at June 30, 2025 · - | ||||
| Issued | 258,144 | $0.001 | 2,429,523 | N/A |
| Exercised | - | |||
| Expired and cancelled | - | |||
| Outstanding and exercisable at March 31, 2026 | 258,144 | $0.001 | 2,429,523 | N/A |
Equity Award Plans
On February 17, 2015, the Company’s stockholders approved the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan offered certain employees, directors, and consultants the opportunity to acquire the Company’s common stock subject to service vesting requirements to encourage such persons to remain employed by the Company and to attract new employees. The 2014 Plan allowed for the award of the Company’s common stock and stock options, representing up to 1,000,000 shares of the Company’s common stock. In November 2024, the 2014 Plan expired pursuant to its terms and no shares of the Company’s common stock remain available for future grants under the 2014 Plan.
On April 29, 2021, the Company’s stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan authorizes the issuance of awards for up to 2,000,000 shares of common stock in the form of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and unrestricted stock awards to officers, directors and employees of, and consultants and advisors to, the Company or its affiliates. As of March 31, 2026,434,126 shares of the Company’s common stock were available for future grants under the 2021 Plan.
On May 28, 2025, the Company’s stockholders approved the 2025 Equity Incentive Plan (the “2025 Plan”). The 2025 Plan authorizes the issuance of awards for up to 1,000,000 shares of common stock in the form of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and unrestricted stock awards to officers, directors and employees of, and consultants and advisors to, the Company or its affiliates. As of March 31, 2026,1,000,000 shares of the Company’s common stock were available for future grants under the 2025 Plan.
Stock Options
Activity in the Company’s stock options during the nine months ended March 31, 2026 and related balances outstanding as of that date are reflected below:
| Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contract Term (years) | Aggregate intrinsic Value | Weighted Average Grant Date Fair Value | |
|---|---|---|---|---|---|
| Outstanding at June 30, 2025 | 796,660 | $4.10 | $3.08 | ||
| Granted | 536,239 | $1.88 | $1.23 | ||
| Exercised | (62,125) | $4.10 | $3.40 | ||
| Forfeited and cancelled | (304,440) | $3.43 | $115,095 | $2.54 | |
| Outstanding at March 31, 2026 | 966,334 | $3.08 | 6.75 | $2.21 | |
| Exercisable at March 31, 2026 | 729,335 | $3.47 | 6.23 | $2.52 | |
Page 17
Activity in the Company’s stock options during the nine months ended March 31, 2025 and related balances outstanding as of that date are reflected below:
| Number of Shares · Weighted Average Exercise Price · Weighted Average Remaining Contract Term (years) · Aggregate intrinsic Value · Weighted Average Grant Date Fair Value | |||
|---|---|---|---|
| Outstanding at June 30, 2024 | 1,605,060 | $4.85 | |
| Granted | - | ||
| Exercised | - | ||
| Forfeited and cancelled | (387,535) | $3.39 | |
| Outstanding at March 31, 2025 | 1,217,525 | $5.32 | 5.34 |
| Exercisable at March 31, 2025 | 766,905 | $6.39 | 3.60 |
The Company uses the Black-Scholes valuation model to calculate the fair value of stock options at the date of grant. Weighted average annualized percentages and expected term inputs used in Black-Scholes valuations during the periods listed below are:
| Nine Months Ended March 31, | ||||
|---|---|---|---|---|
| 2026 | 2025 (1) | |||
| Expected volatility | 95.46% | - | ||
| Risk free interest rate | 3.85% | - | ||
| Dividend yield | 0% | - | ||
| Expected term (years) | 5.87 | |||
| (1) | No stock options were issued during the nine months ended March 31, 2025. |
Restricted Stock Units and Performance Stock Units
The Company’s Equity Award Plans allows for grants of Restricted Stock Units (“RSUs”), which include performance-based stock units (“PSUs”). The awards are subject to the terms and conditions provided in (i) the Restricted Stock Unit Award Agreement for time-based awards, and (ii) the Performance Restricted Stock Unit Award Agreement for PSUs. Subject to vesting requirements set forth in the applicable RSU or PSU award agreement, one share of common stock is issuable for one vested RSU or PSU, as applicable. The fair value of time-based RSUs and PSUs without a market condition is the closing stock price of the Company’s common stock on the date of grant. The fair value of PSUs with market conditions is determined using the Monte Carlo valuation method.
On April 18, 2024, a total of 68,228 time-based RSUs were authorized by the Company’s Board of Directors to be granted to the Company’s four non-executive directors under the amended 2014 Plan and the 2021 Plan. On May 28, 2025, a total of 200,000 time-based RSUs were authorized by the Company’s Board of Directors to be granted to the Company’s four non-executive directors under the 2021 Plan.
On August 1, 2025, a total of 121,951 time-based RSUs were granted by the Company’s Board of Directors under the 2021 Plan to the Company’s Chief Executive Officer (“CEO”). Also on August 1, 2025, a total of 182,927 PSUs were granted by the Company’s Board of Directors under the 2021 Plan to the Company’s CEO, of which 122,561 PSUs contained only performance conditions and 60,366 PSUs contained a market condition.
Page 18
Activity in RSUs, including PSUs, during the nine months ended March 31, 2026 and related balances outstanding as of that date are reflected below:
| Number of Shares | Weighted Average Grant Date Fair Value | Weighted Average Remaining Contract Term (years) | |
|---|---|---|---|
| Outstanding at June 30, 2025 | 200,000 | $1.60 | 0.91 |
| Granted | 304,878 | $1.43 | 0.16 |
| Vested and settled | - | ||
| Forfeited and cancelled | - | ||
| Outstanding at March 31, 2026 | 504,878 | $1.50 | 1.44 |
Activity in RSUs during the nine months ended March 31, 2025 and related balances outstanding as of that date are reflected below:
| Number of Shares | Weighted Average Grant Date Fair Value | Weighted Average Remaining Contract Term (years) | |
|---|---|---|---|
| Outstanding at June 30, 2024 | 114,666 | $5.56 | |
| Granted | - | ||
| Vested and settled | (34,668) | $7.30 | |
| Forfeited and cancelled | (11,770) | $8.00 | |
| Outstanding at March 31, 2025 | 68,228 | $4.25 | 0.05 |
Employee Stock Purchase Plan
On March 6, 2023, the Company’s Board of Directors approved the 2023 Employee Stock Purchase Plan (the “2023 ESPP”), and on April 20, 2023, the 2023 ESPP was approved by the Company’s stockholders. The 2023 ESPP enables eligible employees of the Company and certain of its subsidiaries (a “Participating Subsidiary”) to use payroll deductions to purchase shares of the Company’s Common Stock and acquire an ownership interest in the Company. The maximum aggregate number of shares of the Company’s Common Stock that have been reserved as authorized for the grant of options under the 2023 ESPP is 350,000 shares, subject to adjustment as provided for in the 2023 ESPP. Participation in the 2023 ESPP is voluntary and is limited to eligible employees (as such term is defined in the 2023 ESPP) of the Company or a Participating Subsidiary who (i) has been employed by the Company or a Participating Subsidiary for at least 90 days and (ii) is customarily employed for at least twenty (20) hours per week and more than five (5) months in any calendar year. Each eligible employee may authorize payroll deductions of 1-15% of the eligible employee’s compensation on each pay day to be used to purchase up to 1,500 shares of Common Stock for the employee’s account occurring during an offering period. The 2023 ESPP has a term of ten (10) years commencing on April 20, 2023, the date of approval by the Company’s stockholders, unless otherwise earlier terminated.
Page 19
Under the provisions of the 2023 ESPP, participants purchase common stock at 85% of the closing price of the Company’s common stock at the start or end of each six-month offering period, whichever is lower. Common stock purchases under the 2023 ESPP are reflected below:
| Common Stock | Price per Share | |
|---|---|---|
| Shares authorized under the 2023 ESPP | 350,000 | |
| Purchase - March 28, 2024 | 37,543 | $2.80 |
| Purchase - September 30, 2024 | 20,987 | $2.58 |
| Purchase - March 31, 2025 | 29,350 | $1.46 |
| Purchase - September 30, 2025 | 26,312 | $1.39 |
| Purchase - March 31, 2026 | 21,248 | $0.91 |
| Available under the 2023 ESPP as of March 31, 2026 | 214,560 |
Stock-based Compensation Expense
Stock-based compensation (“SBC”) expense represents the estimated fair value of stock options, RSUs, PSUs and ESPP shares at the beginning of each offering period, amortized under the straight-line method over the requisite service period and reduced for estimated forfeitures. For PSUs with only performance conditions, recognition of SBC expense is delayed until the performance-based vesting conditions are deemed probable of being achieved, at which time the unrecognized SBC to date is recognized. For PSUs with market conditions, SBC expense is recognized beginning on the date of grant over the requisite service period regardless of whether the market condition is ultimately satisfied.
At March 31, 2026, none of the PSUs with performance only conditions were deemed to be probable of achievement and no related stock-based compensation has been recognized to date. The following table summarizes SBC expense:
| Three months ended March 31, | Nine months ended March 31, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Selling and administrative | $220,000 | $161,000 | $694,000 | $730,000 |
| Research and development | 20,000 | 45,000 | 40,000 | 101,000 |
| Total stock-based compensation expense | $240,000 | $206,000 | $734,000 | $831,000 |
At March 31, 2026, the unamortized SBC expense related to outstanding stock options and RSUs was approximately $1,075,000 and $459,000, respectively, expected to be expensed over the weighted-average remaining recognition period 1.33 years andone year, respectively.
At March 31, 2025, the unamortized SBC expense related to outstanding stock options and RSUs was approximately $927,000 and $17,000, respectively, expected to be expensed over the weighted-average remaining recognition period of 1.22 years andone month, respectively.
Page 20
NOTE 9 –NET LOSS PER SHARE
Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period.
For the three and nine months ended March 31, 2026 and 2025, diluted net loss per common share is the same as basic net loss per common share as the inclusion of potentially dilutive securities would have been anti-dilutive. Potentially dilutive securities excluded from the calculation of diluted weighted-average common shares outstanding were as follows:
| Three months ended March 31, | Nine months ended March 31, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Stock options | 966,424 | 1,217,525 | 998,679 | 1,411,711 |
| RSUs(1) | 514,878 | - | 479,253 | 76,754 |
| Common Stock Warrants convertible to common stock | 2,496,198 | 1,413,110 | 2,159,256 | 1,413,110 |
| Preferred Stock Warrants convertible to common stock | 2,429,523 | - | 1,755,641 | - |
| Total potentially dilutive securities | 6,407,023 | 2,630,635 | 5,392,829 | 2,698,863 |
| (1) | RSUs presented include performance stock units with goals that management determined are not probable to be achieved. |
NOTE 10 –CONCENTRATIONS
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and unsecured trade accounts receivable. The Company maintains cash balances in non-interest-bearing bank deposit accounts at a California commercial bank. The Company’s cash balance at this institution is secured by the Federal Deposit Insurance Corporation up to $250,000. As of March 31, 2026 and June 30, 2025, the cash balance was approximately $372,000 and $1,334,000, respectively.
The Company has not experienced any losses in such accounts. Management believes that the Company is not exposed to any significant credit risk with respect to its cash.
Customer Concentrations
During the three months ended March 31, 2026, the Company had four major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $5,920,000 or 90% of total revenues. During the nine months ended March 31, 2026, the Company had two major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $24,614,000 or 73% of total revenues.
During the three months ended March 31, 2025, the Company had four major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $14,815,000 or 88% of total revenues. During the nine months ended March 31, 2025, the Company had three major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $36,211,000 or 73% of total revenues.
Suppliers/Vendor Concentrations
The Company obtains components and supplies included in its products from a group of suppliers. The Company does not manufacture the battery cells used in energy storage solutions. Battery cells, which are an integral part of energy storage solutions, are sourced from a single manufacturer located in China. In response to business uncertainties resulting from tariffs and increased tariff levels imposed by the U.S. government on goods imported into the U.S., imports from the battery cell supplier in China were temporarily paused. The pause was short-lived as both parties quickly agreed to modified terms. Currently, neither the pause in shipments nor the modified terms have materially affected the Company’s operations. However, further escalation of tariffs between the U.S. and China could have a material effect on the Company’s ability to cost-effectively source from the supplier in China.
During the three months ended March 31, 2026, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $2,123,000 or 28% of total purchases. During the nine months ended March 31, 2026, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $6,963,000 or 23% of total purchases.
During the three months ended March 31, 2025, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $5,413,000 or 34% of total purchases. During the nine months ended March 31, 2025, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $12,931,000 or 30% of total purchases.
Page 21
NOTE 11 -COMMITMENTS AND CONTINGENCIES
Legal Proceedings
From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in any legal proceedings that may arise from time to time may harm the Company’s business. To the best of its knowledge, except for the legal proceedings disclosed below, there are no other material legal proceedings pending against the Company.
Employment-Related Actions
On April 30, 2024, a former employee (the “Employee”) filed a class action complaint against the Company and Insperity, its third-party payroll service provider, in San Diego County Superior Court for claims including failure to pay minimum wage, failure to pay overtime, failure to provide meal periods, failure to provide rest breaks, failure to pay wages at separation, failure to provide accurate wage statements, failure to reimburse business expenses, failure to produce employment records and unfair competition, which he has purported to assert on behalf of himself and all other individuals who worked for the Company or Insperity, as non-exempt employees in California between April 30, 2020 and the present (the “Employment Proceeding”). On July 1, 2024, the Company filed an answer to the complaint that none of the asserted claims possessed any merit, contended that many of the asserted claims were subject to immediate dismissal, and contended that certain of the asserted claims were subject to binding arbitration.
On July 5, 2024, the Employee filed a representative action complaint against the Company and Insperity in San Diego County Superior Court for Violation of Private Attorneys’ General Act (“PAGA”), seeking an unspecified amount of penalties and attorneys’ fees based on allegations that the Company violated certain California employment laws (the “PAGA Proceeding”). On August 8, 2024, the Company filed an answer to the complaint in which the Company denied that any of the asserted claims possessed any merit and contended that certain of the asserted claims were subject to binding arbitration. On October 14, 2024, the Employee elected to dismiss Insperity from the action without prejudice.
On December 10, 2024, the Company and the Employee stipulated to the consolidation of Employment Lawsuit and the PAGA Action. As of the date hereof, both proceedings are currently pending consolidation by the court. Upon consolidation, the Company intends to move to have the Employee’s action claims dismissed, the Employee’s individual claims compelled to binding arbitration and the Employee’s representative PAGA claims stayed pending the arbitration of his individual claims. On October 22, 2024, the Employee elected to dismiss Insperity from the action without prejudice.
The plaintiff’s Class Action lawsuit and Plaintiff’s PAGA lawsuit have now been consolidated by the Court. Plaintiff has refused to dismiss his Class Action claims or submit his individual claims, including his individual PAGA claims, to binding arbitration. Accordingly, at the January 24, 2025 Case Management Conference in this matter, the Court authorized the Company to proceed with the filing of a Motion to Compel Arbitration. The Motion to Compel Arbitration was granted and arbitration was scheduled for March 26, 2026 wherein the parties agreed to a settlement of $164,000.
Final settlement is subject to, among other things, court approval of such agreement. If the settlement does not obtain approval, the parties agree that the settlement class will be decertified without prejudice, and that all the parties will revert to their pre-settlement positions.
Page 22
Leases Obligations
Future Minimum Lease Payments as of March 31, 2026 are as follows:
| Operating Leases · Finance Leases | ||
|---|---|---|
| Fiscal years ending June 30, | ||
| 2026 (remaining three months) | $228,000 | $40,000 |
| 2027 | 433,000 | 54,000 |
| 2028 | 64,000 | 21,000 |
| Total future minimum lease payments | 725,000 | 115,000 |
| Less: discount | (21,000) | (6,000) |
| Total lease liability | 704,000 | 109,000 |
| Less: leases payable, current portion | (621,000) | (87,000) |
| Leases payable, noncurrent portion | $83,000 | $22,000 |
Operating Leases
The Company has operating leases for industrial and commercial buildings and facilities with initial terms of five to seven years, expiring between November 2026 and April 2028, some of which include options to extend the leases. The Company’s operating leases have stated lease payments, which may include fixed rental increases.
Total rent expense, including the Company’s portion of common area maintenance and other costs allocated between tenants, was approximately $228,000 and $679,000 for the three months and nine months ended March 31, 2026, respectively, and $232,000 and $697,000 for the three and nine months ended March 31, 2025, respectively.
Finance Leases
The Company has finance leases for certain vehicles and manufacturing equipment with initial terms of three to five years. In September 2025, a 36-month equipment lease was extended for an additional 12 months, resulting in a $66,000 increase to the right-of-use asset’s carrying value. In October 2025, a 36-month equipment lease was extended for an additional 12 months, resulting in a $73,000 increase to the right-of-use asset’s carrying value.
Lease costs are amortized on a straight-line basis over their respective lease terms. Amortization expense related to leased assets was approximately $38,000 and $117,000 for the three and nine months ended March 31, 2026, respectively, and $38,000 and $117,000 for the three and nine months ended March 31, 2025, respectively.
Interest expense on leased liabilities was approximately $3,000 and $8,000 for the three months and nine months ended March 31, 2026, respectively. Interest expense on leased liabilities was approximately $4,000 and $14,000 for the three and nine months ended March 31, 2025, respectively.
Page 23
NOTE 12 –SEGMENT INFORMATION
The Company hasone business activity and derives its revenue from the design, development, manufacturing and sale of a portfolio of advanced lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling and airport ground support equipment. Accordingly, the Company operates as a single operating and reporting segment. The Company’s chief operating decision maker (the “CODM”) is its Chief Executive Officer. The CODM reviews financial information including operating results and assets on a consolidated basis.
When evaluating the Company’s financial performance and making strategic decisions, the CODM uses net income (loss) and Adjusted EBITDA to assess performance and allocate financial, capital and personnel resources. Net income (loss) and Adjusted EBITDA are used in the annual operating plan and forecasting process as well as ongoing decisions driven by the monthly or quarterly reviews of the plan versus actual results.
The table below is a summary of the segment profit or loss, including significant segment expenses, for the periods presented:
| Three months ended March 31, | Nine months ended March 31, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenues | $6,588,000 | $16,742,000 | $33,884,000 | $49,697,000 |
| Less: | ||||
| Cost of sales | 4,788,000 | 11,455,000 | 23,424,000 | 33,729,000 |
| General and administrative | 3,158,000 | 4,577,000 | 9,846,000 | 13,822,000 |
| Selling and marketing | 767,000 | 892,000 | 2,047,000 | 2,245,000 |
| Research and development | 623,000 | 1,147,000 | 2,196,000 | 3,419,000 |
| Depreciation | 243,000 | 248,000 | 745,000 | 750,000 |
| Interest expense (net) | 184,000 | 362,000 | 762,000 | 1,227,000 |
| Net loss | $(3,175,000) | $(1,939,000) | $(5,136,000) | $(5,495,000) |
Assets provided to the CODM are consistent with those reported on the consolidated balance sheets. All long-lived assets are held in the United States, and revenues and net losses are solely generated from operations in the United States.
**NOTE 13 –SUBSEQUENT EVENTS **
Management evaluated events subsequent to March 31, 2026 through the filing date of these unaudited condensed consolidated financial statements. On April 3, 2026, Management received a Notice of Default and Reservation of Rights from GBC due to the Company’s failure to comply with the minimum EBITDA financial covenant for the trailing three-month period ended March 31, 2026, which resulted in an event of default under the GBC Credit Facility. The Company is working with GBC to negotiate an amendment to the GBC Credit Facility or otherwise obtain a waiver from GBC. GBC has allowed the Company to continue to have access to its line of credit under the GBC Credit Facility while negotiations continue, however, GBC can choose to limit this access at any time until the Company can successfully negotiate an amendment to the GBC Credit Facility or obtain a waiver from GBC. While the Company has in the past successfully renegotiated the terms of the GBC Credit Facility, and is optimistic about its ability to do so again, there can be no assurances that the Company will be able to negotiate an amendment to the GBC Credit Facility or obtain a waiver from GBC on terms favorable to the Company or at all. See Note 1.
Notwithstanding, management concluded there are no other material subsequent events to disclose.
Page 24
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.